Krystal Biotech (KRYS) FCF Margin (2023 - 2026)
Krystal Biotech (KRYS) posted quarterly FCF Margin of 59.74% for Q2 2026, up 682.0% year-over-year from 7.64% in Q2 2025, and down 5.05% on a QoQ basis from 62.92% in Q1 2026.
Powered by 
Analysis
Krystal Biotech (KRYS) FCF Margin (2023 - 2026) Analysis & Trends
Krystal Biotech has reported FCF Margin for 4 years, with the latest figure at 59.74% in Q2 2026.
- FCF Margin for Q2 2026 came in at 59.74%, up 682.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 58.52% (up 636.0% YoY), and the FY2025 annual result was 48.55%, up 899.0% from the prior year.
- FCF Margin slipped to 59.74% in Q2 2026, from 62.92% in the prior quarter.
- Over five years, FCF Margin peaked at 70.53% in Q3 2024 and troughed at 249.31% in Q3 2023.
- A 4-year average of 15.28% and a median of 45.86% in 2025 frame the typical range for FCF Margin.
- The widest annual swing landed in 2024, when FCF Margin surged 31984 bps; it then sank 3172 bps in 2025.
- A 4-year view of FCF Margin shows it stood at 18.81% in 2023, then jumped by 407 bps to 57.77% in 2024, then grew by 22 bps to 70.37% in 2025, then slipped by 15 bps to 59.74% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 59.74% in Q2 2026, 62.92% in Q1 2026, and 70.37% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Krystal Biotech | 10.61 Bn | 9.76 Bn | 112.79 Mn | 59.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.74% |
| Mar 31, 2026 | 62.92% |
| Dec 31, 2025 | 70.37% |
| Sep 30, 2025 | 38.81% |
| Jun 30, 2025 | 52.92% |
| Mar 31, 2025 | 28.08% |
| Dec 31, 2024 | 57.77% |
| Sep 30, 2024 | 70.53% |
| Jun 30, 2024 | -6.09% |
| Mar 31, 2024 | 16.41% |
| Dec 31, 2023 | -18.81% |
| Sep 30, 2023 | -249.31% |